Genmab | Beneficio Operativo



Operating Profit Cambio Fecha
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
Almirall EUR 43.02M 8.82M 2025-06
Amarin USD -16755000 35.77M 2025-03
Amgen USD 2.66B 1.37B 2025-06
argenx SE USD 203.84M 64.9M 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Bayer EUR 13M 2.31B 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Demant DKK 1.87B 471M 2025-06
Exelixis USD 215.68M 28.82M 2025-07
Fresenius Medical Care EUR 431M 100M 2025-06
Galapagos EUR -57027000 101.68M 2025-06
Genmab DKK 360M 172M 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
GN Store Nord DKK 215M 486M 2025-03
GRIFOLS EUR 349.54M 80.68M 2025-06
Hikma Pharmaceutical USD 282M 45M 2024-12
Insmed USD -253876000 5.74M 2025-06
Lonza CHF 430M 104M 2024-12
Merck EUR 1.03B 24M 2025-06
Novartis USD 4.86B 201M 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 1.71B 573M 2025-06
UCB EUR 1B 678M 2024-12


Genmab Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.